Holen Sie sich die Stockscreener-App
37.87
0.85%
0.32
Handel nachbörslich:
38.17
0.30
+0.79%
Schlusskurs vom Vortag:
$37.55
Offen:
$37.55
24-Stunden-Volumen:
438.72K
Relative Volume:
0.56
Marktkapitalisierung:
$2.18B
Einnahmen:
$772.53M
Nettoeinkommen (Verlust:
$180.90M
KGV:
12.21
EPS:
3.1024
Netto-Cashflow:
$258.73M
1W Leistung:
+1.20%
1M Leistung:
-2.70%
6M Leistung:
+15.63%
1J Leistung:
+9.67%
1-Tages-Spanne:
$37.20
$37.92
1-Wochen-Bereich:
$35.42
$38.11
52-Wochen-Spanne:
$25.52
$40.93
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Vergleichen Sie HRMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
37.87 | 2.16B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Will Harmony Biosciences Holdings Inc. stock outperform growth indexesJuly 2025 Price Swings & Weekly Setup with High ROI Potential - ulpravda.ru
6 Analysts Have This To Say About Harmony Biosciences Hldgs - Benzinga
Truist Securities Lowers Price Target for HRMY Amidst Current Buy Rating | HRMY Stock News - GuruFocus
HRMY vs. LQDA: Which Stock Is the Better Value Option? - Yahoo Finance
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Oklahoma City NewsThe Oklahoman - FinancialContent
Harmony Biosciences Holdings (HRMY) Stock Analysis: A Revenue Growth Powerhouse with 25.66% Upside Potential - DirectorsTalk Interviews
Harmony Biosciences Launches Early Trial of Promising Orexin Agonist - MSN
Market Might Still Lack Some Conviction On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Even After 26% Share Price Boost - 富途牛牛
Top 5 US Stocks To Buy In January 2026 - Investing.com
(HRMY) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
26,279 Shares in Harmony Biosciences Holdings, Inc. $HRMY Acquired by Paradiem LLC - MarketBeat
Exchange Traded Concepts LLC Buys 32,923 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc Stock Analysis and ForecastContrarian Investment Ideas & Big Gains Small Trading - earlytimes.in
Quarterly Trades: What is the fair value of Harmony Biosciences Holdings Inc stock nowTrade Risk Summary & Daily Oversold Stock Bounce Ideas - moha.gov.vn
Why Harmony Biosciences Holdings Inc. stock is popular among millennials2025 Growth vs Value & Daily Market Momentum Tracking - Улправда
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Can Harmony Biosciences Holdings Inc. stock maintain operating marginsJuly 2025 Gainers & Reliable Volume Spike Alerts - Улправда
Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study - MyChesCo
Why Harmony Biosciences Holdings Inc. stock attracts high net worth investors2025 Price Targets & Daily Entry Point Alerts - DonanımHaber
Why Harmony Biosciences Holdings Inc. stock appeals to dividend seekersJuly 2025 Outlook & Verified Chart Pattern Trade Signals - DonanımHaber
Will Harmony Biosciences Holdings Inc. stock outperform value stocksBull Run & Safe Entry Momentum Tips - Улправда
Downgrade Watch: Is Harmony Biosciences Holdings Inc. stock positioned well for digital economyWatch List & Stepwise Swing Trade Plans - DonanımHaber
Dow Update: Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones indexWeekly Trend Summary & Long-Term Growth Plans - Улправда
How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutEarnings Growth Summary & Trade Opportunity Analysis Reports - Улправда
Is Harmony Biosciences Holdings Inc. stock resilient to inflation2025 Winners & Losers & Community Consensus Trade Signals - Улправда
Harmony Biosciences (NASDAQ:HRMY) Trading Down 3.9% After Insider Selling - MarketBeat
Street Watch: Will Harmony Biosciences Holdings Inc. stock outperform international peersJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Aug Wrap: How sustainable is Harmony Biosciences Holdings Inc. stock dividend payoutJuly 2025 Breakouts & Technical Entry and Exit Alerts - Улправда
Will Harmony Biosciences Holdings Inc. stock outperform Dow Jones index2026 world cup usa national team qualification young talents low block defense match prediction insights - Улправда
Harmony Biosciences (NASDAQ:HRMY) CEO Sells $1,040,172.63 in Stock - MarketBeat
Harmony Biosciences Holdings CEO Sells All Directly Owned Common Stock - TradingView — Track All Markets
Harmony Biosciences CEO reports option exercise and share sale | HRMY SEC FilingForm 4 - Stock Titan
Harmony Biosciences (HRMY): Evaluating Valuation After New EPX-100 Phase 3 Data and Beacon Biosignals Collaboration - Sahm
Harmony Biosciences partners with Beacon for EEG data in sleep trials - Investing.com Nigeria
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG - Investing News Network
Harmony Biosciences partners with Beacon for EEG data in sleep trials By Investing.com - Investing.com South Africa
Beacon Biosignals announces partnership with Harmony Biosciences - marketscreener.com
Nomura Holdings Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Harmony Biosciences Appoints Ron Philip to Board of Directors - MSN
Growth Value: Will Harmony Biosciences Holdings Inc stock pay special dividendsTrade Ideas & Real-Time Buy Zone Alerts - moha.gov.vn
Federated Hermes Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Shows Niche Pharma Momentum Nasdaq Today - Kalkine Media
Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
What analysts say about Harmony Biosciences Holdings Inc stockAutomated Trading Signals & Missed Nvidia? Don’t Miss This One - earlytimes.in
Harmony Biosciences CFO Kapadia Sandip Sells 20,000 Shares - TradingView — Track All Markets
Harmony Advances Pitolisant GR After Bioequivalence Success - Sleep Review
Harmony Biosciences Prepares to Court Investors at Key December Healthcare Conferences - MSN
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):